Skip to main navigation Skip to search Skip to main content

Non-canonical role of cancer-associated mutant SEC23B in the ribosome biogenesis pathway

  • Cleveland Clinic Foundation
  • Cleveland State University
  • Case Western Reserve University
  • Taussig Cancer Center
  • Case Western Reserve University

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

SEC23B is a component of coat protein complex II (COPII) vesicles that transport secretory proteins from the endoplasmic reticulum (ER) to the Golgi apparatus. Loss-of-function SEC23B mutations cause a rare form of anemia, resulting from decreased SEC23B levels. We recently identified germline heterozygous SEC23B variants as potentially cancer-predisposing. Mutant SEC23B associated with ER stress-mediated tumorigenesis, without decreased SEC23B expression. However, our understanding of the processes behind these observations remain limited. Here, we show mutant SEC23B exists within nucleoli, in addition to classical distribution at the ER/Golgi. This occurs independent of other COPII proteins and does not compromise secretory function. Mutant cells have increased ribosomal protein and translation-related gene expression, and enhanced translational capacity, in the presence of ER stress. We show that mutant SEC23B binds to UBF transcription factor, with increased UBF transcription factor binding at the ribosomal DNA promoter. Our data indicate SEC23B has potential noncanonical COPII-independent function, particularly within the ribosome biogenesis pathway, and that may contribute to the pathogenesis of cancer-predisposition.
Original languageEnglish
Pages (from-to)3154-3164
Number of pages11
JournalHuman Molecular Genetics
Volume27
Issue number18
DOIs
StatePublished - Sep 15 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this